Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological processes in benzodiazepine dependence

M Lader1

  • 1Institute of Psychiatry, London, UK.

Addiction (Abingdon, England)
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A patient who changed my practice: Personality disorder or bipolar disorder?

International journal of psychiatry in clinical practice·2014
Same author

Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.

European psychiatry : the journal of the Association of European Psychiatrists·2012
Same author

Plasma concentrations of tricyclic antidepressive drugs.

British journal of clinical pharmacology·2012
Same author

Caffeine withdrawal symptoms and rate of metabolism.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Buspirone treatment as an aid to benzodiazepine withdrawal.

Journal of psychopharmacology (Oxford, England)·2012
Same author

A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety.

Journal of psychopharmacology (Oxford, England)·2012
Same journal

Longitudinal association of switching to dual cigarette and e-cigarette use vs. continued exclusive cigarette smoking with tobacco-specific nitrosamine and nicotine intake.

Addiction (Abingdon, England)·2026
Same journal

Novel product, familiar challenges: Navigating uncertainty in oral nicotine pouch regulation.

Addiction (Abingdon, England)·2026
Same journal

Craving and personal functioning as mediators of extended-release buprenorphine efficacy: A four-way decomposition analysis from a randomised trial.

Addiction (Abingdon, England)·2026
Same journal

Alcohol consumption and the risks of morbidity and mortality across 39 diseases and conditions: A population-based cohort study in Korea.

Addiction (Abingdon, England)·2026
Same journal

A cross-sectional and prospective examination of alcohol use and misuse among adult twin and sibling pairs discordant for neighborhood socio-economic disadvantage.

Addiction (Abingdon, England)·2026
Same journal

The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity.

Addiction (Abingdon, England)·2026
See all related articles

Benzodiazepines treat anxiety and insomnia by enhancing GABA effects. Long-term use alters receptor function, and flumazenil can manage withdrawal symptoms.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Benzodiazepines are indicated for anxiety, insomnia, muscle spasms, and epilepsy.
  • Limbic structures and neurotransmitters like GABA, noradrenaline, and 5-HT are implicated in these disorders.
  • Benzodiazepines potentiate GABA's inhibitory effects by modulating chloride ionophores.

Purpose of the Study:

  • To explore the molecular pharmacology of the benzodiazepine-GABA-chloride receptor.
  • To investigate the effects of long-term benzodiazepine use on receptor function and dependence.
  • To examine the clinical implications of benzodiazepine receptor interactions, including the role of flumazenil.

Main Methods:

  • Review of molecular pharmacology of the benzodiazepine-GABA-chloride receptor.

Related Experiment Videos

  • Analysis of animal models of benzodiazepine dependence.
  • Exploration of clinical data regarding benzodiazepine use and withdrawal.

    • Main Results:

    • The benzodiazepine-GABA-chloride receptor complex is molecularly complex with diverse subunits.
    • Long-term benzodiazepine use leads to adaptive changes in receptor-effector coupling, affecting agonist and antagonist efficacy.
    • Flumazenil, a benzodiazepine antagonist, can block benzodiazepine effects and is explored for managing withdrawal.

    Conclusions:

    • Understanding the complex molecular pharmacology of benzodiazepine receptors is crucial.
    • Long-term benzodiazepine use induces changes in receptor-effector coupling, impacting drug efficacy and dependence.
    • Flumazenil presents potential clinical utility in preventing and treating benzodiazepine withdrawal syndromes.